Saturday, October 22, 2016

Effect of soy on metabolic syndrome and cardiovascular risk factors: A randomized controlled trial

Yet, this will NEVER be translated into a diet protocol publicly available to all. We have complete incompetency in our fucking failures of stroke associations. I've only referenced that failure 242 times. How can the employees, presidents and boards of directors live with themselves?
https://www.mdlinx.com/internal-medicine/medical-news-article/2016/10/19/soy-proteinlipidsmetabolic-syndrome-and-obesity/6910172/?news_id=387&newsdt=102216&subspec_id=4&utm_source=WeeklyNL&utm_medium=newsletter&utm_content=Weeks-Best-Article&


European Journal of Nutrition, 10/19/2016

Ruscica M, et al. – Researchers conducted this study to determine the impact of soy on metabolic syndrome and cardiovascular risk factors. It was observed in the findings that the inclusion of whole soy foods in a lipid–lowering diet significantly enhanced a relevant set of biomarkers connected with cardiovascular risk.

Methods


  • The study was composed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks.
  • To pursue this research whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount.

Results


  • Researchers found that soy nutritional intervention resulted in a lessening in the number of MetS features in 13/26 subjects.
  • In addition, in the soy group they observed a significant improvement of median percentage changes for body weight (-1.5 %) and BMI (-1.5 %), and additionally for atherogenic lipid markers, namely TC (-4.85 %), LDL-C (-5.25 %), non-HDL-C (-7.14 %) and apoB (-14.8 %).
  • Since the majority of the studied variables were strongly correlated, 3 factors were identified which explained the majority (52 %) of the total variance in the whole data set.
  • Among them, factor 1, which loaded lipid and adipose variables, clarified the 22 % of aggregate variance, demonstrating a statistically significant difference between treatment arms (p = 0.002).


Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report

No comments:

Post a Comment